INTRODUCTION
============

The metabolic syndrome (MetS), globally is a major health problem associated with increased morbidity and mortality from Cardiovascular disease (CVD). MetS is a conglomerate of various risk factors which is known to increase the risk for development of CVD. Various terms which have been ascribed for this constellation of findings are syndrome X, insulin resistance syndrome, "deadly quartet" and obesity dyslipidemia syndrome \[[@b1-jlm-09-044],[@b2-jlm-09-044]\]. MetS represents a group of cardiovascular risk factors, including Hyperglycemia, elevated Blood Pressure (BP), elevated Triglyceride (TG) levels, central obesity and decreased High-Density Lipoprotein Cholesterol (HDL-C) \[[@b3-jlm-09-044]\]. It will exacerbate the progression of CVD if left untreated. The estimates of the prevalence of MetS ranged from 21.3% to 32.8% among the participants in the Framingham Offspring Study and San Antonio Heart Study \[[@b4-jlm-09-044]\].

The prevalence of MetS is high among Asians including Indians, and is rising, particularly with the adoption of modernized lifestyle. Many studies in India have reported a high prevalence of MetS \[[@b5-jlm-09-044]--[@b7-jlm-09-044]\]. The number of people with the MetS also differs by sex, race, and ethnicity \[[@b8-jlm-09-044]\]. In the United States of America, the prevalence of the MetS in the adult population was estimated to be more than 25%. Similarly, the prevalence of MetS in 7 European countries was approximately 23%. It was estimated that 20--25% of South Asians have developed MetS and many more may be prone to it \[[@b9-jlm-09-044],[@b10-jlm-09-044]\].

Nationally representative studies regarding the prevalence of the MetS are generally not available from any South Asian country. Available data indicate that the prevalence of the MetS in Asian Indians varies according to region, extent of urbanization, lifestyle patterns, and socioeconomic/ cultural factors \[[@b11-jlm-09-044]\]. Overall prevalence ranges between 10 to 40% depending on age and sex. Recent data show that about one-third of the urban population in large cities in India have MetS \[[@b12-jlm-09-044],[@b13-jlm-09-044]\]. In a South Indian study, the prevalence of MetS was estimated to be 25.8%, 23.2%, and 18.3% according to the International Diabetes Federation (IDF), World Health Organization (WHO), and National Cholesterol Education Program(NCEP)--Adult Treatment Panel (ATP) III definitions, respectively, implicating a discord between the same \[[@b7-jlm-09-044]\].

The rural prevalence of MetS is found to be reasonably low compared to the urban prevalence. A recent survey in Central India observed an overall MetS prevalence as per NCEP ATP III criteria to be 5.0% in the adult rural population. When NCEP ATP III criteria were modified using waist circumference (WC) cut- offs recommended by Asia-Pacific guidelines, MetS was seen in 9.3% (8.2% in males and 10.7% in females) \[[@b14-jlm-09-044]\].

Selvaraj et al. conducted a study in the rural background in Tamil Nadu among women with prevalence of 30.7% \[[@b15-jlm-09-044]\]. Scanty information is available about the magnitude of MetS in the rural areas especially young adult Males in India including Tamil Nadu. Hence the present study was undertaken in the rural area of Kancheepuram district with a primary objective, to estimate the prevalence of MetS among men in the age group of 20--40 years of rural population and to evaluate the association of life style risk factors with MetS.

The prevalence of this syndrome is high among Asians, including Indians, and is rising, especially in the rural background area. However, not many studies were focused on young adult men in the rural area of Tamil Nadu. Hence, the objectives were to estimate the prevalence of Metabolic Syndrome among adult men 20--40 years and to assess the association between the life style risk factors and metabolic syndrome in Kancheepuram district.

MATERIALS AND METHODS
=====================

A cross-sectional study conducted from June 2015 to July 2016 in a rural population served by SRM Rural Health Centre, Kancheepuram district, about 84 Kms away from Chennai City. The present study was conducted among the population from 9 villages (Mamandur, Vadapathy, Meiyur, S.Mambakkam, Sirupinayur, Thiruvanthavur, Kodithandalam, Natarajapuram, Samathuvapuram) with total population of 13,493. Among which, overall 6554 were males and the 20--40 years old age group numbered 3011 were included in this study. Participants who were not available in their households at the time of data collection and who all were not willing to participate in the study were excluded. As per NCEP ATP III criteria, the overall prevalence of metabolic syndrome in India including urban, rural and tribal areas ranges from 30 to 50% \[[@b16-jlm-09-044]--[@b18-jlm-09-044]\] and taking the prevalence as 32% with limit of accuracy 5%, the sample size was worked out to be 334. The anticipated non-response in providing blood samples was 10% and accordingly to compensate for the non-response, the final sample size arrived at was 360.

The Men in the age group of 20--40 years were listed out from the Family Folder list which was maintained in the SRM Rural Health Center, Kancheepuram District for the year 2014. They were serially numbered. Using this as the sampling frame, 360 men were selected by Probability Proportional to Size (PPS) from 9 villages. From each village, subjects were selected by simple random sampling using computer random number generator.

1. Ethical approval
-------------------

Institutional ethical committee approval was obtained prior to the start of study and informed consent was taken from all the study subjects.

2. Metabolic syndrome definition
--------------------------------

Modified NCEP ATP III definition \[[@b19-jlm-09-044]\].

The clinical components of metabolic syndrome include abdominal obesity, high triglyceride, low high density- lipoprotein cholesterol, high blood pressure, and high fasting glucose. The 2001 ATP III definition requires the presence of three or more of the following five components:

1.  Waist Circumference ＞ 90 cm in men and ＞ 85 cm in women,

2.  Triglycerides ≥ 150 mg/dL or drug treatment for Hypertriglyceridemia,

3.  HDL-C ＜ 40 mg/dL in men and ＜ 50 mg/dL in women or drug treatment for low HDL-C,

4.  Blood pressure ≥ 130/85 mmHg or drug treatment for previously diagnosed hypertension, and

5.  FBG ≥ 110 mg/dl or drug treatment for elevated glucose.

3. Data collection
------------------

Pre-designed, pre-tested, semi-structured questionnaire with few modifications for the present study were further validated and detailed information regarding demographic, socioeconomic, behavioral and health status was collected from each study subject. Anthropometric measurements (waist circumference (WC), weight and height) and blood pressure were obtained using standard procedures. Privacy of each participant was strictly considered when taking the measurements.

4. Laboratory method
--------------------

Blood samples were drawn using standard phlebotomy procedure from an antecubital vein between 8 am and 9 am after a 12--14 hour overnight fast. They were analyzed for fasting glucose levels, serum triglycerides (enzymatic kit methods: Vital Diagnostics Pvt. Ltd, Mumbai); and serum High Density Lipoprotein (HDL-C) (Kit method: Bayer Diagnostics, Baroda) using a semi-auto-analyzer from an accredited lab (ISO certified) located at Tambaram, Chennai. The Laboratory results were validated with another lab of same ISO standards and every 50th participant's results were validated to rule out any misinterpretations.

5. Data analysis and statistical methods
----------------------------------------

The collected data was analyzed using relevant descriptive and inferential statistical techniques using Statistical Package for the Social Sciences (SPSS) for Windows 20.0 (SPSS Inc.,) Illinois, Chicago. Magnitude of MetS was expressed in percentage and 95% confidence interval (CIs). Chi-square tests were used to study associations between categorical variables. Unadjusted odds ratio (ORs) were computed to assess the strength of association between independent variables (age, sex, socioeconomic status, smoking and alcohol and family history of HTN, DM) and dependent variables (MetS) along with their 95% CIs. All statistical tests were considered statistically significant when two-sided p \< 0.05.

RESULTS
=======

The Demographic information profile of the study participants is provided in [Table 1](#t1-jlm-09-044){ref-type="table"} and, their biochemical and clinical profile in [Table 2](#t2-jlm-09-044){ref-type="table"}. The prevalence of MetS was found to be 16.7%. In this study, the mean age of the study participants was 29.18 (± 6.738) years. The mean BMI of the study participants was 23.6 (± 3.7). The mean Systolic BP was 118.5 (± 5.7) mmHg. The mean Diastolic BP was 79.1 (± 5.4) mmHg. The mean Fasting Triglyceride level in this study was 140.6 (± 21.4) mg/dl. Similarly, the mean Fasting HDL levels was 32 (± 4.8) mg/dl. The mean FBS (fasting blood sugar) levels was 86.1 (± 21.7) mg/dl.

The association of demographic variables of the study participants with MetS is shown in [Table 3](#t3-jlm-09-044){ref-type="table"} which showed that men in the age group of 31--40 yrs, married men, un-skilled and semiskilled workers, alcoholics and smokers were at higher risk of developing metabolic syndrome and are statistically significant. [Table 4](#t4-jlm-09-044){ref-type="table"} shows the association of biochemical and clinical variables with MetS were almost all the factors are having risk of developing MetS and was found to be statistically significant at p value ＜ 0.05.

[Table 5](#t5-jlm-09-044){ref-type="table"} shows that after applying binary logistic regression for variables, which was statistically significant using Chi-square test, which revealed strong association of variables such as increased age, Alcohol intake habit, high Waist Circumference, raised TG level, raised FBS level and high average Diastolic BP with Metabolic Syndrome at p value ＜ 0.05.

DISCUSSION
==========

This study showed that the overall prevalence of Metabolic Syndrome (according to mod. NCEP ATP III criteria \[[@b19-jlm-09-044]\]) among men between 20--40 years was 16.7%. The prevalence of metabolic syndrome was increased with age among group 31--40 yrs with 32.4%. Similar findings were reported by Karimi et al. with 18.9% among males in rural community in Iran \[[@b20-jlm-09-044]\] and Deepa et al. reported 17.1% among males in Chennai \[[@b7-jlm-09-044]\]. In contrast, higher prevalence was reported by Peixito et al. \[[@b21-jlm-09-044]\] and Pathania et al. reported with 33.6% among males of rural Goa and Haryana respectively \[[@b22-jlm-09-044]\]. Kamble et al. reported lesser prevalence of 8.2% among rural Wardha men \[[@b23-jlm-09-044]\]. Findings were reported by Jain et al. \[[@b24-jlm-09-044]\], with higher prevalence of MetS among aged more than 25 years than among less than aged 25 years with 14.8% and 7.4% respectively.

Among the five components of metabolic syndrome, most commonly observed component was High Triglycerides followed by High waist circumference and abnormal Diastolic BP with 31%, 14% and 7% respectively. Men who had abnormal Waist Circumference (14.2%) as per NCEP ATP III criteria modified for Asian Indians \[[@b25-jlm-09-044]\] had 14.9 times higher risk of Metabolic Syndrome than those who had normal WC and was highly statistically significant. The association of waist circumference with higher prevalence metabolic syndrome was supported by other authors \[[@b7-jlm-09-044],[@b17-jlm-09-044],[@b22-jlm-09-044],[@b26-jlm-09-044]\]. Similarly, study by Kamble \[[@b23-jlm-09-044]\], 16% of the study participants were with high Waist Circumference. In contrast, higher proportion of participants with high waist circumference 51.7%, was reported by Peixoto et al. \[[@b21-jlm-09-044]\]. Men who had abnormal HDL levels were 2.3 times at higher risk of developing MetS. In contrast, Gyakobo et al. 32.3% prevalence of MetS were reported among low HDL-C level participants and 9.7% prevalence among high TG level participants \[[@b27-jlm-09-044]\]. Positive association of Abnormal Fasting and MetS were observed by many authors \[[@b7-jlm-09-044],[@b17-jlm-09-044],[@b22-jlm-09-044]\]. In contrast, study conducted by Arthi et al. 38% prevalence were observed among the impaired fasting glycemic group and 24% among the Euglycemic group \[[@b26-jlm-09-044]\]. Significant association of SBP and DBP with MetS was reported by Kanjilal, et al. \[[@b28-jlm-09-044]\] similar to our study findings.

After using Binary Logistic Regression, variables like Increased age, Alcohol intake, high Waist Circumference, raised TG level, raised FBS level and high average Diastolic BP were strongly associated with Metabolic Syndrome as it was statistically significant.

The present study being a cross sectional study carries the inherent limitations of cross sectional studies, thereby disabling the understanding of true temporal relationships between lifestyle disease diseases. Cross-sectional data cannot assess the effect of lifestyle on the incidence of MetS, and longitudinal cohort studies are, therefore, needed.

CONCLUSION
==========

This study documents one-fourth of the study population with metabolic syndrome and high proportions were observed in the older age group 31--40 years with 32.4%, on applying the NCEP ATP III (mod) criteria for Asian Indians. The prevalence of Metabolic Syndrome was found to be positively associated with socio-demographic variables like increased age, married men, unskilled workers, positive family history, obese BMI, High Waist circumference, High TG levels, High FBS levels, and high DBP and SBP levels. This revealed that metabolic syndrome (or its contributing variables) could be a major health problem even in rural background, indicating that this syndrome was not necessarily a result of modernization or urbanization. An additional adverse impact of adoption of urban life styles (perhaps primarily mediated through dietary changes) was also apparent on cardiovascular risk factors and metabolic syndrome. Knowledge and awareness about MetS may be imparted through appropriate Information, Education and Communication (IEC) or Behavior Change Communications (BCC) activities about weight reduction, restricting alcohol intake and smoking, increase in physical activity and proper regular screening of Blood Pressure, Blood Sugars and Serum Cholesterol Levels. If abdominal obesity or increased waist circumference is kept at check, MetS incidence can be controlled by and large in the young population, which in turn lowers the chances of MetS incidence with increasing age. However, if 3--6 months of efforts at remedying risk factors prove insufficient, then drug treatment is frequently required. Utilization of this information, early identification, treatment and prevention of the Metabolic Syndrome, present a major challenge for Community Physicians, and public health policy makers and stakeholders in the regional health sector.

###### 

Prevalence of metabolic syndrome based on demographic profile of study participants (N = 360)

  Background variables       Frequency (%)   Metabolic syndrome (%)
  -------------------------- --------------- ------------------------
  Age                                        
   20--30                    212 (58.9)      12 (5.6)
   31--40                    148 (41.1)      48 (32.4)
  Education                                  
   Illiterate                14 (3.8)        3 (21.4)
   School                    258 (71.6)      47 (18.2)
   College                   88 (24.4)       10 (11.3)
  Occupation                                 
   Unskilled                 7 (1.9)         2 (28.6)
   Semi-skilled              226 (62.8)      30 (13.3)
   Skilled                   127 (35.3)      28 (22.0)
  Type of family                             
   Nuclear                   87 (24.2)       16 (19.1)
   Joint                     273 (75.8)      44 (15.9)
  Standard of living index                   
   Low                       6 (1.7)         0 (0)
   Medium                    47 (13.1)       11 (23.4)
   High                      307 (85.2)      49 (15.9)
  Marital status                             
   Unmarried                 166 (46.1)      12 (7.2)
   Married                   194 (53.9)      48 (24.7)
  Smoking habits                             
   Smoker                    29 (8.1)        10 (34.5)
   Non-smoker                331 (91.9)      50 (15.1)
  Alcohol habits                             
   Alcoholic                 55 (15.3)       22 (40.0)
   Non-alcoholic             305 (84.7)      38 (12.5)
  Physical activity                          
   Hepa active               12 (3.3)        3 (25)
   Minimal active            304 (84.4)      45 (14.8)
   Inactive                  44 (12.2)       12 (27.3)

###### 

Prevalence of metabolic syndrome based on biochemical and clinical profile of the study participants (N = 360)

  Background variables             Frequency (%)   Met S(%)
  -------------------------------- --------------- -----------
  Fasting triglyceride level                       
   Normal (\< 150 mg/dl)           248 (68.9)      16 (6.4)
   Abnormal (≥150 mg/dl)           112 (31.1)      44 (39.3)
  Fasting HDL-cholesterol level                    
   ≥40 mg/dl                       347 (96.4)      56 (16.1)
   \<40 mg/dl                      13 (3.6)        4 (30.8)
  Fasting blood sugar                              
   \<110 mg/dl                     344 (95.6)      48 (13.9)
   ≥110 mg/dl                      16 (4.4)        12 (75)
  Systolic blood pressure                          
   \<130 mm Hg                     353 (92.8)      48 (13.9)
   ≥130 mm Hg                      26 (7.2)        12 (75)
  Diastolic blood pressure                         
   \<85 mm Hg                      334 (92.8)      43 (12.9)
   ≥85 mm Hg                       26 (7.2)        17 (65.4)
  BMI                                              
   \<24.9                          257 (71.4)      34 (13.2)
   25--29.9                        78 (21.7)       16 (20.5)
   ≥30                             25 (6.9)        10 (40)
  Waist circumference                              
   ≤90 cm                          309 (85.8)      29 (9.4)
   \>90 cm                         51 (14.2)       31 (60.8)
  Family history                                   
   F/H diabetes mellitus           14 (39)         2 (14.3)
   F/H hypertension                6 (1.7)         3 (50)
   F/H diabetes and hypertension   7 (1.9)         4 (57.1)
   No F/H                          333 (92.5)      51 (15.3)

###### 

Association of demographic variables with metabolic syndrome (N = 360)

  Variables                    MetS   Non-MetS   OR     95 CI         *χ*^2^, df & p-value
  ---------------------------- ------ ---------- ------ ------------- ------------------------------------
  Age                                                                 
   31--40                      48     100        8.0    4.07--15.74   *χ*^2^ = 44.98, df = 1, p \< 0.001
   20--30                      12     200                             
  Type of family                                                      
   Nuclear                     16     68         1.24   0.65--2.33    *χ*^2^ = 1.0, df = 1, p = 0.50
   Joint                       44     232                             
  Marital status                                                      
   Married                     48     146        4.22   2.16--8.26    *χ*^2^ = 19.79, df = 1, p \< 0.001
   Unmarried                   12     154                             
  Occupation                                                          
   Unskilled & semi-skilled    30     104        1.88   1.08--3.29    *χ*^2^ = 5.03, df = 1, p = 0.02
   Skilled                     30     196                             
  Standard of living index                                            
   Low & medium                11     42         1.38   0.66--2.86    *χ*^2^ = 0.75, df = 1, p = 0.39
   High                        49     258                             
  Smoking history                                                     
   Smoker                      10     19         2.95   1.29--6.73    *χ*^2^ = 7.20, df = 1, p = 0.007
   Non-smoker                  50     281                             
  Drinking alcoholic history                                          
   Alcoholic                   22     33         4.68   2.47--8.86    *χ*^2^ = 25.44, df = 1, p \< 0.001
   Non-alcoholic               38     267                             
  Physical activity                                                   
   Hepa active                 3      9          1                    
   Minimal active              45     259        0.52   0.14--1.99    *χ*^2^ = 0.03, df = 1, p = 0.58
   Inactive                    12     32         1.13   0.26--4.87    *χ*^2^ = 0.03, df = 1, p = 0.87

MetS: metabolic syndrome, OR: odds ration, CI: confidence interval.

###### 

Association of clinical & biochemical variables with MetS (N = 360)

  Variables                                                  MetS   Non-MetS   OR      95 CI          *χ*^2^, df, & p-value
  ---------------------------------------------------------- ------ ---------- ------- -------------- ------------------------------------
  Triglyceride level                                                                                  
   High                                                      44     68         9.38    4.98--17.67    *χ*^2^ = 59.89, df = 1, p \<0.001
   Normal                                                    16     232                               
  High density lipoprotein-cholesterol                                                                
   Low                                                       4      9          2.309   0.69--7.76     *χ*^2^ = 1.93, df = 1, p = 0.16
   Normal                                                    56     291                               
  Fasting blood sugar                                                                                 
   High                                                      12     4          18.43   5.69--59.67    *χ*^2^ = 41.023, df = 1, p \<0.001
   Normal                                                    48     296                               
  Diastolic blood pressure                                                                            
   \> 85 mm of Hg                                            17     9          12.78   5.36--30.48    *χ*^2^ = 47.89, df = 1, p \<0.001
   \< 85 mm of Hg                                            43     291                               
  Systolic blood pressure                                                                             
   \> 130 mm of Hg                                           6      1          33.22   3.92--281.46   *χ*^2^ = 24.505, df = 1, p \<0.001
   \<130 mm of Hg                                            54     299                               
  Body mass index                                                                                     
   \<24.9                                                    34     223        1                      
   25--29.9                                                  16     62         1.69    0.87--3.27     *χ*^2^ = 2.5, df = 1, p = 0.11
   ≥30                                                       10     15         4.37    1.82--10.51    *χ*^2^ = 12.4, df = 1, p \<0.001
  Waist circumference                                                                                 
   High                                                      31     20         14.96   7.58--29.54    *χ*^2^ = 83.27, df = 1, p \<0.001
   Normal                                                    29     280                               
  Family history of hypertension/diabetes mellitus or both                                            
   Yes                                                       9      18         2.77    1.77--6.49     *χ*^2^ = 5.84, df = 1, p = 0.01
   No                                                        51     282                               

MetS: metabolic syndrome, OR: odds ration, CI: confidence interval.

###### 

Logistic regression of variables with metabolic syndrome

  No.   Variables        B        SE      Wald     df   Sig.    Exp (B)   95 CI for EXP(B)   
  ----- ---------------- -------- ------- -------- ---- ------- --------- ------------------ ---------
  1     Age              2.079    0.345   36.286   1    0.000   8.00      4.067              15.737
  2     Occupation       0.446    0.532   0.701    1    0.402   1.561     0.550              4.430
  3     Marital status   1.081    0.561   3.715    1    0.054   2.946     0.982              8.841
  4     Family history   0.280    0.823   0.116    1    0.734   1.323     0.264              6.635
  5     Smoking          0.293    0.772   0.144    1    0.704   1.340     0.295              6.084
  6     Alcohol          1.624    0.557   8.506    1    0.004   5.074     1.703              15.115
  7     BMI              −0.297   0.523   0.323    1    0.570   0.743     0.267              2.070
  8     WC               3.569    0.630   32.089   1    0.000   35.49     10.323             122.03
  9     TG               3.802    0.665   32.686   1    0.000   44.79     12.167             164.94
  10    FBS              3.898    1.16    11.107   1    0.001   49.28     4.980              487.71
  11    Average SBP      2.914    3.53    0.679    1    0.410   18.43     0.018              18869.8
  12    Average DBP      4.487    0.838   28.653   1    0.000   88.84     17.184             459.31

B: co-efficient, SE: standard error, Wald: Z score, df: degree of freedom, Sig: significancem, Exp (B): odds ratio, CI: confidence Interval, BMI: body mass index, WC: waist circumference, TG: triglycerol, FBS: fasting blood sugar, SBP: systolic blood pressure, DBP: diastolic blood pressure.
